Financial Gravity Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,088
Closed -$2.58K 841
2022
Q1
$2.58K Sell
2,088
-1,234
-37% -$144K 0.07% 241
2021
Q4
$3.31K Buy
+3,322
New +$448K 0.07% 264

Other funds holding TNDM

Financial Gravity Asset Management's TNDM Position: Q2 2022 in Review

Financial Gravity Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,088 shares — an estimated $2.58K sold.

Financial Gravity Asset Management first reported a position in TNDM in Q4 2021 and held it in 2 quarters. The position peaked at $3.31K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Financial Gravity Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2,088 Tandem Diabetes Care shares in Q2 2022, an estimated $2.58K.
  • Financial Gravity Asset Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 2 quarters.
  • Financial Gravity Asset Management's Tandem Diabetes Care position peaked at $3.31K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Financial Gravity Asset Management's 13F filing for Q2 2022, filed 5 Aug 2022.